MA54397A - Compositions microbiennes comprenant de l'ellagitannine et procédés d'utilisation - Google Patents

Compositions microbiennes comprenant de l'ellagitannine et procédés d'utilisation

Info

Publication number
MA54397A
MA54397A MA054397A MA54397A MA54397A MA 54397 A MA54397 A MA 54397A MA 054397 A MA054397 A MA 054397A MA 54397 A MA54397 A MA 54397A MA 54397 A MA54397 A MA 54397A
Authority
MA
Morocco
Prior art keywords
ellagitannin
methods
microbial compositions
microbial
compositions
Prior art date
Application number
MA054397A
Other languages
English (en)
Inventor
Priti H Chatter
Jothi Amaranath Govindan
Elamparithi Jayamani
Original Assignee
Marvelbiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marvelbiome Inc filed Critical Marvelbiome Inc
Publication of MA54397A publication Critical patent/MA54397A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/0102—Tannase (3.1.1.20)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y401/00—Carbon-carbon lyases (4.1)
    • C12Y401/01—Carboxy-lyases (4.1.1)
    • C12Y401/01059—Gallate decarboxylase (4.1.1.59)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Husbandry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA054397A 2018-11-05 2019-11-04 Compositions microbiennes comprenant de l'ellagitannine et procédés d'utilisation MA54397A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862755880P 2018-11-05 2018-11-05
US201962909736P 2019-10-02 2019-10-02

Publications (1)

Publication Number Publication Date
MA54397A true MA54397A (fr) 2022-05-11

Family

ID=70459686

Family Applications (1)

Application Number Title Priority Date Filing Date
MA054397A MA54397A (fr) 2018-11-05 2019-11-04 Compositions microbiennes comprenant de l'ellagitannine et procédés d'utilisation

Country Status (12)

Country Link
US (3) US11122828B2 (fr)
EP (2) EP3891267B1 (fr)
JP (2) JP7638866B2 (fr)
KR (2) KR20240113585A (fr)
CN (2) CN117562174A (fr)
AU (2) AU2019377423B2 (fr)
CA (1) CA3116415A1 (fr)
DK (1) DK3891267T3 (fr)
ES (1) ES2981358T3 (fr)
MA (1) MA54397A (fr)
PT (1) PT3891267T (fr)
WO (1) WO2020096992A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3891267B1 (fr) 2018-11-05 2024-05-29 MarvelBiome, Inc. Compositions microbiennes comprenant de l'ellagitannine et procédés d'utilisation
WO2021252760A2 (fr) 2020-06-10 2021-12-16 The Board Of Trustees Of The University Of Arkansas Probiotiques d'origine porcine qui favorisent la santé et la performance de croissance chez les porcs
IL301145A (en) 2020-09-11 2023-05-01 Marvelbiome Inc Methods and uses of microbiome compositions
EP4362955A1 (fr) 2021-06-28 2024-05-08 ASC REGENITY Limited Composition nutraceutique de soin de la peau
EP4151222A1 (fr) * 2021-09-15 2023-03-22 Migalis ApS Composition permettant d'optimiser la production d'urolithine chez un sujet humain
CN114790472B (zh) * 2022-03-25 2024-04-16 上海龙殷生物科技有限公司 一种果糖糖基化的姜黄素、制备方法及应用
KR102514059B1 (ko) * 2022-07-12 2023-03-27 (주)스마트푸릇 체내흡수율이 증가된 엘라그산과 갈산을 고함량 포함하는 뼈건강 또는 여성갱년기 증상 개선용 석류 발효조성물 및 efc 공법을 이용한 그의 제조방법
KR102514071B1 (ko) * 2022-08-01 2023-03-28 (주)스마트푸릇 체내흡수율이 증가된 엘라그산과 갈산을 고함량 포함하는 부종 또는 비만 개선용 석류 발효조성물 및 efc 공법을 이용한 그의 제조방법
KR102514074B1 (ko) * 2022-08-10 2023-03-27 (주)스마트푸릇 체내흡수율이 증가된 엘라그산과 갈산을 고함량 포함하는 혈관건강, 전립선 또는 성기능 개선용 석류 발효조성물 및 efc 공법을 이용한 그의 제조방법
CN115992074B (zh) * 2022-11-10 2023-11-28 江南大学 一株植物乳杆菌及其在产生尿石素a中的应用
CN115786190B (zh) * 2022-11-10 2024-03-12 江南大学 一株可产尿石素a抗衰老的植物乳杆菌及其应用
CN118104816A (zh) * 2022-11-30 2024-05-31 武汉蜜欢健康产业发展有限公司 食用组合物及其应用
CN115868540B (zh) * 2022-12-13 2024-08-30 扬州市扬大康源乳业有限公司 一种黑莓酸奶及其制备方法
CN116832054B (zh) * 2023-05-19 2025-12-05 浙江大学 一种水溶性膳食纤维及其在制备促进鞣花酸代谢为尿石素a的药物中的应用和药物组合物
IT202300012771A1 (it) * 2023-06-20 2024-12-20 Unifarco S P A Composizione in polvere e/o granulare a base di estratto di melograno
CN117179153A (zh) * 2023-10-16 2023-12-08 江苏省农业科学院 一种构树青贮饲料发酵用复合生物制剂及其应用
CN118109373B (zh) * 2024-04-30 2024-07-12 山东中科嘉亿生物工程有限公司 一种可合成尿石素a的干酪乳酪杆菌jylc-109及其菌剂和应用
WO2025233971A1 (fr) * 2024-05-10 2025-11-13 Suthar Jaspreet Compositions comprenant un extrait de spectre entier de punica granatum enrichi de manière sélective avec des punicagalines, de l'acide ellagique et de l'urolithine a et son procédé de préparation
EP4721816A1 (fr) * 2024-10-04 2026-04-08 Fundació Institut d'Investigació Sanitària Pere Virgili (IISPV) Enzymes capables de réduire les taux de succinate et leurs utilisations
WO2026074205A1 (fr) * 2024-10-04 2026-04-09 Fundació Institut D’Investigació Sanitària Pere Virgili (Iispv) Enzymes capables de réduire les taux de succinate et leurs utilisations

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225202A (en) 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
US5733575A (en) 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
IL127378A (en) 1996-06-06 2003-07-31 Bifodan As Enteric coating for an oral preparation
UA73092C2 (uk) 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
US6139875A (en) 1998-09-29 2000-10-31 Eastman Chemical Company Aqueous enteric coating composition and low gastric permeability enteric coating
US6420473B1 (en) 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
CN100508993C (zh) * 2003-02-17 2009-07-08 表飞鸣制药株式会社 含有肠内细菌的片剂
SE527555C2 (sv) 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
WO2009059175A2 (fr) * 2007-11-01 2009-05-07 Novozymes, Inc. Procédé de réduction de l'effet inhibiteur d'un tanin de l'hydrolyse enzymatique de matériau cellulosique
JP5162212B2 (ja) 2007-11-19 2013-03-13 丸善製薬株式会社 新規乳酸菌、乳酸菌組成物及び植物エキス、並びに、植物エキス及び低分子ポリフェノールの製造方法
ES2356536B1 (es) * 2009-09-23 2012-02-13 Probelte Pharma, Sa Una composición de uso como prebiótico que contiene un extracto de granada y un alimento que incluye dicha composición.
US8257761B2 (en) 2009-12-15 2012-09-04 Jacob Ludwig Manfred Polyphenol-containing products
JP2013103880A (ja) 2011-11-10 2013-05-30 Sunstar Inc 抗酸化機能賦活剤
US9066924B2 (en) * 2011-12-23 2015-06-30 Horphag Research Ip (Qr) Ltd Ellagitannins rich extracts composition in sexual wellness
JP6000022B2 (ja) 2012-08-24 2016-09-28 一丸ファルコス株式会社 ニキビ予防・改善剤および皮膚外用剤組成物
US20160106789A1 (en) 2013-03-14 2016-04-21 Gil NOFAR Inhibition of Neurodegenerative Disease by Grape Seed Extract, Green Tea Extract and Probiotic Bacteria
ES2510216B1 (es) * 2013-03-20 2015-10-27 Consejo Superior De Investigaciones Científicas (Csic) Microorganismo capaz de convertir ácido elágico y elagitaninos en urolitinas y uso del mismo
JP6281905B2 (ja) 2014-03-05 2018-02-21 日本メナード化粧品株式会社 角栓形成抑制剤
MY180486A (en) 2014-06-05 2020-11-30 Univ Malaysia Sabah Method for the production of dried probiotic food
KR101825803B1 (ko) * 2016-02-17 2018-03-22 주식회사 씨앤비코스메틱 마가목추출물의 발효물을 유효성분으로 함유하는 피부노화방지 및 피부주름개선용 화장료 조성물
CN105901741B (zh) * 2016-03-23 2019-03-19 江南大学 一种具有缓解铅毒性功能的益生菌和植物提取物的膳食补充剂
WO2017172766A1 (fr) * 2016-03-28 2017-10-05 The Coca-Cola Company Amélioration de la saveur sucrée et de la saveur d'édulcorants de glycosides de stéviol ou de mogrosides avec des flavonoïdes
US20200164006A1 (en) 2017-05-21 2020-05-28 Innovanutra Inc. Methods and compositions of incorporating a bioactive agent and use thereof
CN107418995B (zh) * 2017-07-26 2019-12-03 枣庄学院 一种石榴皮单宁液态发酵制备的鞣花酸及其制备方法
US20210038654A1 (en) 2018-03-16 2021-02-11 Persephone Biosciences Compositions for modulating gut microflora populations, enhancing drug potency and treating cancer, and methods for making and using same
WO2019212997A1 (fr) * 2018-04-30 2019-11-07 Rejuvenation Therapeutics Compositions et procédés de préparation biosynthétique de composés d'urolithine et leur utilisation
EP3891267B1 (fr) 2018-11-05 2024-05-29 MarvelBiome, Inc. Compositions microbiennes comprenant de l'ellagitannine et procédés d'utilisation

Also Published As

Publication number Publication date
US20200138075A1 (en) 2020-05-07
KR20240113585A (ko) 2024-07-22
US11122828B2 (en) 2021-09-21
JP2025093935A (ja) 2025-06-24
EP3891267A1 (fr) 2021-10-13
AU2019377423A1 (en) 2021-05-20
KR102682981B1 (ko) 2024-07-11
ES2981358T3 (es) 2024-10-08
EP4442832A2 (fr) 2024-10-09
EP3891267B1 (fr) 2024-05-29
AU2019377423B2 (en) 2023-09-21
EP4442832A3 (fr) 2025-01-29
AU2023285750A1 (en) 2024-03-07
US20220022508A1 (en) 2022-01-27
JP2022506748A (ja) 2022-01-17
CA3116415A1 (fr) 2020-05-14
JP7638866B2 (ja) 2025-03-04
CN117562174A (zh) 2024-02-20
CN113543658A (zh) 2021-10-22
EP3891267A4 (fr) 2022-08-24
PT3891267T (pt) 2024-07-04
KR20210114929A (ko) 2021-09-24
WO2020096992A1 (fr) 2020-05-14
US20250228277A1 (en) 2025-07-17
DK3891267T3 (da) 2024-07-08

Similar Documents

Publication Publication Date Title
EP3891267A4 (fr) Compositions microbiennes comprenant de l'ellagitannine et procédés d'utilisation
EP3962296A4 (fr) Compositions de cannabinoïdes et procédés d'utilisation
EP3704239A4 (fr) Compositions de casz et procédés d'utilisation
EP3890736A4 (fr) Agents de dégradations de petites molécules de helios et procédés d'utilisation
EP3790596A4 (fr) Compositions d'oligonucléotides et leurs procédés d'utilisation
EP3775203A4 (fr) Compositions d'oligonucléotides et leurs procédés d'utilisation
EP4051386A4 (fr) Agents de dégradation à petites molécules d'hélios et procédés d'utilisation
EP4037695A4 (fr) Compositions oligonucléotidiques et leurs procédés d'utilisation
EP3958872A4 (fr) Compositions d'oligonucléotides et leurs procédés d'utilisation
EP3634430A4 (fr) Agents multibiotiques et procédés d'utilisation de ceux-ci
EP3752166A4 (fr) Agents de liaison trialcyne et procédés d'utilisation
EP3893917A4 (fr) Compositions d'il-15 et leurs procédés d'utilisation
MA53235A (fr) Indoles substitués et procédés d'utilisation associés
EP3962481A4 (fr) Inhibiteurs de kcnt1 et procédés d'utilisation
EP3962479A4 (fr) Inhibiteurs de kcnt1 et procédés d'utilisation
MA48797A (fr) Variants de l'endonucléase cblb , compositions et procédés d'utilisation
EP3525764A4 (fr) Composition orale d'extraits de cannabinoïdes et procédés d'utilisation
EP3856214A4 (fr) Compositions microbiennes et méthodes d'utilisation
EP3768677A4 (fr) Compositions d'activateurs de canal kv7 et procédés d'utilisation
MA54148A (fr) Mélanges et compositions comprenant de la 5-fluoro-4-imino-3-méthyl-1-tosyl-3,4-dihydropyrimidin-2-one et leurs procédés d'utilisation
EP4034605A4 (fr) Compositions de polissage et leurs procédés d'utilisation
EP3917543A4 (fr) Compositions de nitrate améliorées et procédés d'utilisation
EP3803403A4 (fr) Compositions et procédés d'imagerie
EP3826641A4 (fr) Compositions d'anticorps anti-fcrn et leurs procédés d'utilisation
EP4045226A4 (fr) Compositions de polissage et leurs procédés d'utilisation